No applicable
Conditions
Interventions
Consume two tablets of test food a day for eight weeks. Visit the clinic four weeks and eight weeks after starting consumption of the test food, then receive blood test and answer the questionnaire.
C
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Healthy females aged 20 to 59 years old. (2) Subjects who showed under 12.0g/dL of blood hemoglobin concentration and who are distinguished as mild anemia. (3) Subjects who show understanding of the study procedures and agreement with participating the study by written informed consent prior to the study.
Exclusion criteria
Exclusion criteria: (1)Subjects who receive medical treatment of anemia. (2)Subjects who are dysmenorrhea. (3)Subjects who are after menopause. (4)Subjects who have an excessive unbalanced diet. (5)Subjects who have regularly used medicine, quasi-drugs, supplement and/or health food those concerned have an influence for the test, during 3 months before starting consumption of the test food. (6) Subjects who conduct excess diet control and weight control, and/or who have irregular meal customs (7)Subjects who are pregnant (including the possibility of pregnancy) or are lactating. (8)Subjects who have severe past and/or current medical history in heart, liver, kidney and/or digestive organs. (9) Subjects who are heavy drinkers of alcohol. (10) Subjects who have allergy to medicine and/or food. (11) Subjects who are participating, who have participated within 4 weeks and/or who plan to participate after informed consent of this test, in clinical test of other medicine or health food. (12) Subjects who are lactose intolerance. (13) Subjects who donated over 200mL blood and/or blood components within a month to the current study. (14) Subjects who donated over 400mL blood within the last 4 months to the current study. (15) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last 12 months are adding to the planned sampling amounts of this study. (16) Others they have been determined ineligible by principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin concentration | — |
Secondary
| Measure | Time frame |
|---|---|
| Mean Corpuscular Volume (MCV) Reticlocyte count Serum ferritin concentration Total iron binding capacity(TIBC) Red blood cell Mean Corpuscular hemoglobin(MCH) Mean Corpuscular hemoglobin concentration (MCHV) Hematocrit Serum iron concentration Folic acid concentration Questionnaire of anemia subjective symptom | — |
Countries
Japan
Contacts
Public ContactMakoto Ichinohe
CPCC Company Limited Planning & Sales Department
Outcome results
None listed